Bone formation induced by BMP-2 in human osteosarcoma cells

International Journal of Oncology

Volumn 43, Issue 4, 2013, Pages 1095-1102

  Wang, Lin ^a   Park, Paul ^a   Marca, Frank La ^a   Than, Khoi ^a   Rahman, Shayan ^a   Lin, Chia Ying ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

BMP 2; Bone formation; MAPK; Osteogenic differentiation; Osteosarcoma; Smad

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMAD PROTEIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE MARROW CELL; BONE MINERAL; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOPLASM; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; OSSIFICATION; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALDEHYDE DEHYDROGENASE; ANIMALS; BONE DENSITY; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; OSTEOGENESIS; OSTEOSARCOMA;

EID: 84882417063     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2030     Document Type: Article

References (49)

1. Ottaviani G and Jaffe N: The epidemiology of osteosarcoma. Cancer Treat Res 152: 3-13, 2009.
2. Gorlick R and Khanna C: Osteosarcoma. J Bone Miner Res 25: 683-691, 2010.
3. Shimo T, Matsumura S, Ibaragi S, et al: Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells. J Cell Commun Signal 1: 103-111, 2007.
4. Luk F, Yu Y, Dong HT, Walsh WR and Yang JL: New gene groups associated with dissimilar osteoblastic differentiation are linked to osteosarcomagenesis. Cancer Genomics Proteomics 8: 65-75, 2011.
5. Hruska KA, Mathew S and Saab G: Bone morphogenetic proteins in vascular calcification. Circ Res 97: 105-114, 2005.
6. Barboza E, Caula A and Machado F: Potential of recombinant human bone morphogenetic protein-2 in bone regeneration. Implant Dent 8: 360-367, 1999.
7. Hay E, Lemonnier J, Fromigue O, Guenou H and Marie PJ: Bone morphogenetic protein receptor IB signaling mediates apoptosis independently of differentiation in osteoblastic cells. J Biol Chem 279: 1650-1658, 2004.
8. Wrana JL: Regulation of Smad activity. Cell 100: 189-192, 2000.
9. Moustakas A and Heldin CH: Non-Smad TGF-beta signals. J Cell Sci 118: 3573-3584, 2005.
10. Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G and Caverzasio J: Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res 18: 2060-2068, 2003.
11. Arnold SF, Tims E and McGrath BE: Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2. Cytokine 11: 1031-1037, 1999.
12. Hardwick JC, Van Den Brink GR, Bleuming SA, et al: Bone morphogenetic protein 2 is expressed by and acts upon, mature epithelial cells in the colon. Gastroenterology 126: 111-121, 2004.
13. Kleeff J, Maruyama H, Ishiwata T, et al: Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology 116: 1202-1216, 1999.
14. Soares AF, Xavier RL, da Costa Miguel MC, de Souza LB and Pinto LP: Bone morphogenetic protein-2/4 and bone morphogenetic protein receptor type IA expression in metastatic and nonmetastatic oral squamous cell carcinoma. Am J Otolaryngol 31: 266-271, 2010.
15. Kim IY, Lee DH, Lee DK, et al: Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells. Clin Cancer Res 9: 6046-6051, 2003.
16. Katoh M and Terada M: Overexpression of bone morphogenic protein (BMP)-4 mRNA in gastric cancer cell lines of poorly differentiated type. J Gastroenterol 31: 137-139, 1996.
17. Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P and Langenfeld J: The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24: 1445-1454, 2003.
18. Langenfeld EM, Kong Y and Langenfeld J: Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene 25: 685-692, 2006.
19. Ide H, Yoshida T, Matsumoto N, et al: Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res 57: 5022-5027, 1997.
20. Beck SE, Jung BH, Fiorino A, et al: Bone morphogenetic protein signaling and growth suppression in colon cancer. Am J Physiol Gastrointest Liver Physiol 291: G135-G145, 2006.
21. Brubaker KD, Corey E, Brown LG and Vessella RL: Bone morphogenetic protein signaling in prostate cancer cell lines. J Cell Biochem 91: 151-160, 2004.
22. Ghosh-Choudhury N, Woodruff K, Qi W, Celeste A, Abboud SL and Ghosh Choudhury G: Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation. Biochem Biophys Res Commun 272: 705-711, 2000.
23. Kawamura C, Kizaki M, Yamato K, et al: Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood 96: 2005-2011, 2000.
24. Wen XZ, Miyake S, Akiyama Y and Yuasa Y: BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. Biochem Biophys Res Commun 316: 100-106, 2004.
25. Wang L, Park P, Zhang H, et al: BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell line. Cancer Biol Ther 11: 457-463, 2011.
26. Wang L, Park P, Zhang H, et al: BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation. Int J Cancer 131: 1941-1950, 2012.
27. Gillette JM, Gibbs CP and Nielsen-Preiss SM: Establishment and characterization of OS 99-1, a cell line derived from a highly aggressive primary human osteosarcoma. In Vitro Cell Dev Biol Anim 44: 87-95, 2008.
28. Wang L, Park P, Zhang H, La Marca F and Lin CY: Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity. Int J Cancer 128: 294-303, 2011.
29. Eguchi Y, Wakitani S, Imai Y, et al: Antitumor necrotic factor agent promotes BMP-2-induced ectopic bone formation. J Bone Miner Metab 28: 157-164, 2010.
30. Luo X, Chen J, Song WX, et al: Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest 88: 1264-1277, 2008.
31. Le Page C, Puiffe ML, Meunier L, et al: BMP-2 signaling in ovarian cancer and its association with poor prognosis. J Ovarian Res 2: 4, 2009.
32. Kuo PL, Hsu YL, Chang CH and Chang JK: Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells. J Pharmacol Exp Ther 314: 1290-1299, 2005.
33. Mirabello L, Troisi RJ and Savage SA: International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 125: 229-234, 2009.
34. Tang N, Song WX, Luo J, Haydon RC and He TC: Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res 466: 2114-2130, 2008.
35. Wozney JM, Rosen V, Celeste AJ, et al: Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534, 1988.
36. Katsuno Y, Hanyu A, Kanda H, et al: Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene 27: 6322-6333, 2008.
37. Piccirillo SG, Reynolds BA, Zanetti N, et al: Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765, 2006.
38. Nozaki K, Kadosawa T, Nishimura R, Mochizuki M, Takahashi K and Sasaki N: 1,25-Dihydroxyvitamin D3, recombinant human transforming growth factor-beta 1 and recombinant human bone morphogenetic protein-2 induce in vitro differentiation of canine osteosarcoma cells. J Vet Med Sci 61: 649-656, 1999.
39. Orui H, Imaizumi S, Ogino T and Motoyama T: Effects of bone morphogenetic protein-2 on human tumor cell growth and differentiation: a preliminary report. J Orthop Sci 5: 600-604, 2000.
40. Ma Y, Ma L, Guo Q and Zhang S: Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients. J Exp Clin Cancer Res 29: 85, 2010.
41. Hall AK and Miller RH: Emerging roles for bone morphogenetic proteins in central nervous system glial biology. J Neurosci Res 76: 1-8, 2004.
42. Lee J, Son MJ, Woolard K, et al: Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13: 69-80, 2008.
43. Yamate J, Kotera T, Kuwamura M and Kotani T: Potential osteogenic differentiation of cisplatin-resistant rat malignant fibrous histiocytoma-derived cell lines. Exp Toxicol Pathol 58: 299-309, 2007.
44. Reddi AH: Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am 83-A (Suppl 1): S1-S6, 2001.
45. Ulsamer A, Ortuno MJ, Ruiz S, et al: BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J Biol Chem 283: 3816-3826, 2008.
46. Nakashima K, Zhou X, Kunkel G, et al: The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29, 2002.
47. zur Nieden NI, Kempka G and Ahr HJ: In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 71: 18-27, 2003.
48. Nohe A, Keating E, Knaus P and Petersen NO: Signal transduction of bone morphogenetic protein receptors. Cell Signal 16: 291-299, 2004.
49. Fong S, Chan MK, Fong A, Bowers WJ and Kelly KJ: Viral vector-induced expression of bone morphogenetic protein 2 produces inhibition of tumor growth and bone differentiation of stem cells. Cancer Gene Ther 17: 80-85, 2010.